Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)

Multidrug resistance (MDR) has become a major obstacle in the treatment of cancer, and is associated with mechanisms such as increased drug outflow, reduction of apoptosis, and/or altered drug metabolism. These problems can be mitigated by the coadministration of agents known as chemosensitizers, as...

Full description

Bibliographic Details
Main Authors: Jessica Nayelli Sanchez-Carranza, Leticia González-Maya, Rodrigo Said Razo-Hernández, Enrique Salas-Vidal, Ninfa Yaret Nolasco-Quintana, Aldo F. Clemente-Soto, Lucero García-Arizmendi, Mariana Sánchez-Ramos, Silvia Marquina, Laura Alvarez
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/11/10/512
_version_ 1817996744185610240
author Jessica Nayelli Sanchez-Carranza
Leticia González-Maya
Rodrigo Said Razo-Hernández
Enrique Salas-Vidal
Ninfa Yaret Nolasco-Quintana
Aldo F. Clemente-Soto
Lucero García-Arizmendi
Mariana Sánchez-Ramos
Silvia Marquina
Laura Alvarez
author_facet Jessica Nayelli Sanchez-Carranza
Leticia González-Maya
Rodrigo Said Razo-Hernández
Enrique Salas-Vidal
Ninfa Yaret Nolasco-Quintana
Aldo F. Clemente-Soto
Lucero García-Arizmendi
Mariana Sánchez-Ramos
Silvia Marquina
Laura Alvarez
author_sort Jessica Nayelli Sanchez-Carranza
collection DOAJ
description Multidrug resistance (MDR) has become a major obstacle in the treatment of cancer, and is associated with mechanisms such as increased drug outflow, reduction of apoptosis, and/or altered drug metabolism. These problems can be mitigated by the coadministration of agents known as chemosensitizers, as they can reverse resistance to anticancer drugs and eventually resensitize cancer cells. We explore the chemosensitizing effect of Achillin, a guaianolide-type sesquiterpene lactone isolated from the Mexican medicinal plant <i>Artemisia ludovisiana</i>, to reverse MDR in Hep3B/PTX cells of hepatocellular carcinoma, which present resistance to paclitaxel (PTX). Achillin showed an important effect as chemosensitizer; indeed, the cytotoxic effect of PTX (25 nM) was enhanced, and the induction of G2/M phase cell cycle arrest and apoptosis were potentiated when combining with Achillin (100 &#956;M). In addition, we observed that Achillin decreases P-gp levels and increases the intracellular retention of doxorubicin in Hep3B/PTX cells; in addition, homology structural modeling and molecular docking calculations predicted that Achillin interacts in two regions (M-site and R-site) of transporter drug efflux P-glycoprotein (P-gp). Our results suggest that the chemosensitizer effect demonstrated for Achillin could be associated with P-gp modulation. This work also provides useful information for the development of new therapeutic agents from guaianolide-type sesquiterpene lactones like Achillin.
first_indexed 2024-04-14T02:26:35Z
format Article
id doaj.art-82ceffc9034d465da36b789c5ddfa0de
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-14T02:26:35Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-82ceffc9034d465da36b789c5ddfa0de2022-12-22T02:17:51ZengMDPI AGPharmaceutics1999-49232019-10-01111051210.3390/pharmaceutics11100512pharmaceutics11100512Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)Jessica Nayelli Sanchez-Carranza0Leticia González-Maya1Rodrigo Said Razo-Hernández2Enrique Salas-Vidal3Ninfa Yaret Nolasco-Quintana4Aldo F. Clemente-Soto5Lucero García-Arizmendi6Mariana Sánchez-Ramos7Silvia Marquina8Laura Alvarez9Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoCentro de Investigación en Dinámica Celular-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62209, Morelos, MexicoCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoCentro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, MexicoMultidrug resistance (MDR) has become a major obstacle in the treatment of cancer, and is associated with mechanisms such as increased drug outflow, reduction of apoptosis, and/or altered drug metabolism. These problems can be mitigated by the coadministration of agents known as chemosensitizers, as they can reverse resistance to anticancer drugs and eventually resensitize cancer cells. We explore the chemosensitizing effect of Achillin, a guaianolide-type sesquiterpene lactone isolated from the Mexican medicinal plant <i>Artemisia ludovisiana</i>, to reverse MDR in Hep3B/PTX cells of hepatocellular carcinoma, which present resistance to paclitaxel (PTX). Achillin showed an important effect as chemosensitizer; indeed, the cytotoxic effect of PTX (25 nM) was enhanced, and the induction of G2/M phase cell cycle arrest and apoptosis were potentiated when combining with Achillin (100 &#956;M). In addition, we observed that Achillin decreases P-gp levels and increases the intracellular retention of doxorubicin in Hep3B/PTX cells; in addition, homology structural modeling and molecular docking calculations predicted that Achillin interacts in two regions (M-site and R-site) of transporter drug efflux P-glycoprotein (P-gp). Our results suggest that the chemosensitizer effect demonstrated for Achillin could be associated with P-gp modulation. This work also provides useful information for the development of new therapeutic agents from guaianolide-type sesquiterpene lactones like Achillin.https://www.mdpi.com/1999-4923/11/10/512achillinchemosensitizationmultidrug resistancepaclitaxelhepatocellular carcinomap-glycoprotein
spellingShingle Jessica Nayelli Sanchez-Carranza
Leticia González-Maya
Rodrigo Said Razo-Hernández
Enrique Salas-Vidal
Ninfa Yaret Nolasco-Quintana
Aldo F. Clemente-Soto
Lucero García-Arizmendi
Mariana Sánchez-Ramos
Silvia Marquina
Laura Alvarez
Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
Pharmaceutics
achillin
chemosensitization
multidrug resistance
paclitaxel
hepatocellular carcinoma
p-glycoprotein
title Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
title_full Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
title_fullStr Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
title_full_unstemmed Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
title_short Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
title_sort achillin increases chemosensitivity to paclitaxel overcoming resistance and enhancing apoptosis in human hepatocellular carcinoma cell line resistant to paclitaxel hep3b ptx
topic achillin
chemosensitization
multidrug resistance
paclitaxel
hepatocellular carcinoma
p-glycoprotein
url https://www.mdpi.com/1999-4923/11/10/512
work_keys_str_mv AT jessicanayellisanchezcarranza achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT leticiagonzalezmaya achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT rodrigosaidrazohernandez achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT enriquesalasvidal achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT ninfayaretnolascoquintana achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT aldofclementesoto achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT lucerogarciaarizmendi achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT marianasanchezramos achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT silviamarquina achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx
AT lauraalvarez achillinincreaseschemosensitivitytopaclitaxelovercomingresistanceandenhancingapoptosisinhumanhepatocellularcarcinomacelllineresistanttopaclitaxelhep3bptx